Neurostech is a medtech&pharma company encompassing the development of innovative medical devices and pharma products for neurological conditions.
Neurostech is specialized in targeting the cerebrospinal fluid (CSF). Our intrathecal precision dosing and biodistribution platform that incorporates deep knowledge of CSF dynamics and bioengineering. The company integrates innovation in neuroscience, precision dosing platforms, and manufacturing capabilities to deliver transformative therapies to patients. This comprehensive approach allows to better target the pathophysiology and anatomy specific to various neurological diseases. 

We are a group of scientists and management professionals from the biotech / medtech sector with more than 20 years of experience in either biotech companies or research&innovation centres.

We aim to slow down disease progression and improve the quality of life of patients and families.


Our mission is to deliver breakthroughs that change patient’s lives.

We are particularly committed to neurodegenerative disorders, a series of prevalent conditions affecting millions of patients worldwide with no curative treatment today.

Gabriel Álvarez Menéndez

MSc in Analytical & Biochemistry Sciences. CEO & Co-founder.

Catuxa Prado

PhD Biochemistry. CSO & Co-founder.

Rafael Martínez Permuy

Corporate Development Manager.

Baudilio Zapico Casas

Business Development Director.

María Rodríguez Cañón

María Rodríguez Cañón

PhD Biomedical Engineer.

Ester Pérez Martín

PhD Neurobiology.

Claudia Roces Llorián